El índice h5 es el índice h de los artículos publicados en los últimos 5 años completos. Se trata del número mayor h en cuanto a que h artículos publicados entre 2014 - 2018 deben tener al menos h citas cada uno.ocultar
La mediana h5 de una publicación es el número mediano de citas de los artículos que componen el índice h5.ocultar
Título / AutorCitado porAño
Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
SE Inzucchi, RM Bergenstal, JB Buse, M Diamant, E Ferrannini, M Nauck, ...
Diabetologia 58 (3), 429-442
5562015
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
MJ Davies, DA D’Alessio, J Fradkin, WN Kernan, C Mathieu, G Mingrone, ...
Diabetologia 61 (12), 2461-2498
4342018
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
European Association for the Study of the Liver, ...
Diabetologia 59 (6), 1121-1140
3712016
Molecular mechanisms of diabetic cardiomyopathy
H Bugger, ED Abel
Diabetologia 57 (4), 660-671
3652014
Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events
SAE Peters, RR Huxley, M Woodward
Diabetologia 57 (8), 1542-1551
2712014
The mechanisms of action of metformin
G Rena, DG Hardie, ER Pearson
Diabetologia 60 (9), 1577-1585
2192017
Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort
H Cederberg, A Stančáková, N Yaluri, S Modi, J Kuusisto, M Laakso
Diabetologia 58 (5), 1109-1117
2162015
Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial
P Gæde, J Oellgaard, B Carstensen, P Rossing, H Lund-Andersen, ...
Diabetologia 59 (11), 2298-2307
2052016
Altered DNA methylation and differential expression of genes influencing metabolism and inflammation in adipose tissue from subjects with type 2 diabetes
E Nilsson, P Jansson, A Perilyev, M Pedersen, MK Svensson, P Poulsen, ...
DIABETOLOGIA 57, S152-S152
1982014
Pathophysiology of diabetic dyslipidaemia: where are we?
B Vergès
Diabetologia 58 (5), 886-899
1942015
Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes
International Hypoglycaemia Study Group
Diabetologia 60 (1), 3-6
1862017
Metformin and the gastrointestinal tract
LJ McCreight, CJ Bailey, ER Pearson
Diabetologia 59 (3), 426-435
1802016
Epigenetic mechanisms in diabetic complications and metabolic memory
MA Reddy, E Zhang, R Natarajan
Diabetologia 58 (3), 443-455
1792015
Adipose tissue macrophages: going off track during obesity
L Boutens, R Stienstra
Diabetologia 59 (5), 879-894
1762016
The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study
JP Krischer, KF Lynch, DA Schatz, J Ilonen, Å Lernmark, WA Hagopian, ...
Diabetologia 58 (5), 980-987
1722015
Heme oxygenase-1 drives metaflammation and insulin resistance in mouse and man
A Jais, E Einwallner, O Sharif, M Bilban, C Duvigneau, C Lumeng, ...
DIABETOLOGIA 57, S102-S102
1682014
GLUT2, glucose sensing and glucose homeostasis
B Thorens
Diabetologia 58 (2), 221-232
1622015
The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells
RA Oram, AG Jones, REJ Besser, BA Knight, BM Shields, RJ Brown, ...
Diabetologia 57 (1), 187-191
1542014
SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?
N Sattar, J McLaren, SL Kristensen, D Preiss, JJ McMurray
Diabetologia 59 (7), 1333-1339
1502016
Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition
V Vallon, SC Thomson
Diabetologia 60 (2), 215-225
1382017
1 - 20
Las fechas y los recuentos de citas son estimados y se determinan de forma automática mediante un programa informático.